about
A Transcriptional Signature of Fatigue Derived from Patients with Primary Sjögren's Syndrome.Baseline serum MMP-3 levels in patients with Rheumatoid Arthritis are still independently predictive of radiographic progression in a longitudinal observational cohort at 8 years follow upSubjective and Objective Measures of Dryness Symptoms in Primary Sjögren's Syndrome - Capturing the discrepancy.Autonomic symptoms are common and are associated with overall symptom burden and disease activity in primary Sjogren's syndrome.Fatigue in primary Sjögren's syndrome is associated with lower levels of proinflammatory cytokinesPhysical activity but not sedentary activity is reduced in primary Sjögren's syndrome.Eligibility for clinical trials in primary Sjögren's syndrome: lessons from the UK Primary Sjögren's Syndrome Registry.Health-related utility values of patients with primary Sjögren's syndrome and its predictors.Possible miliary tuberculosis during adalimumab therapy with negative gamma-IFN release assays.Weekly alendronate-induced acute pseudogout.Successful treatment of multicentric reticulohistiocytosis with leflunomide.Do the EULAR Sjögren's syndrome outcome measures correlate with health status in primary Sjögren's syndrome?CTLA4 exon 1 polymorphism, rheumatoid arthritis and autoimmune endocrinopathyAn association between the CTLA4 exon 1 polymorphism and early rheumatoid arthritis with autoimmune endocrinopathiesCopying clinic letters to patients will place additional demands on both secondary and primary care: a hospital outpatient questionnaireBiomarkers predict radiographic progression in early rheumatoid arthritis and perform well compared with traditional markers
P50
Q35875673-96706562-F91F-4191-BE09-C3EA80FECC97Q36085007-B439C317-B8EA-4EBC-9E03-D06280DE0AF3Q36228694-5FACF2F8-7C93-4735-956C-4D6D1F69E6B8Q36370494-160FD7D0-B3AE-419D-A4BE-93D44429C501Q37133826-75D7F3B2-6C53-495F-AD71-94EA8315154CQ37709971-8369FFF6-1E90-4D8A-BA28-0C7DFC8C02F3Q40383414-A26FB875-6075-4177-810E-F4324C25B861Q43439981-23C10689-0A23-437F-9F5C-439D2697FB54Q44659013-EDA3F40E-A47C-4EDC-8A00-3D05EB9D8466Q45195960-D6187E61-1084-44D2-906F-6BAE5A8233CFQ46014260-44601E9B-EBEB-4C44-9E98-EDC3D7C56C85Q48065000-29A9C3F3-6961-4382-B744-0101DBED0F54Q56903177-2F6C1789-0E8C-4E1B-8ABD-C47EA2CDA3BFQ56904666-F53D961B-9886-41FA-AD23-EC1BDAAED5EAQ80788067-A54DAC84-6164-4BEF-949A-7FEDC7F22536Q81377123-A36A6716-0DA7-4518-B41E-5FCD92702CD6
P50
description
researcher
@en
researcher
@en-gb
wetenschapper
@nl
հետազոտող
@hy
name
Steven Young-Min
@ast
Steven Young-Min
@en
Steven Young-Min
@en-gb
Steven Young-Min
@es
Steven Young-Min
@nl
Steven Young-Min
@sl
type
label
Steven Young-Min
@ast
Steven Young-Min
@en
Steven Young-Min
@en-gb
Steven Young-Min
@es
Steven Young-Min
@nl
Steven Young-Min
@sl
prefLabel
Steven Young-Min
@ast
Steven Young-Min
@en
Steven Young-Min
@en-gb
Steven Young-Min
@es
Steven Young-Min
@nl
Steven Young-Min
@sl
P106
P21
P31
P496
0000-0001-8270-6207